Diagnostic Yield of Next-Generation Sequencing for Rare Pediatric Genetic Disorders: A Single-Center Experience
Medical Sciences · 09.06.2025 · 13 (2) · 75
DOI: 10.3390/medsci13020075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Sciences, online erschienen am 09.06.2025. Verfasst von Milena Stoyanova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Medical University Varna, Marin Drinov Str 55, 9000 Varna, Bulgaria. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Rare Diseases, Genetic Diseases, Inborn. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study is financed by the European Union-NextGenerationEU, through the National Recov-ery and Resilience Plan of the Republic of Bulgaria, project № BG-RRP…, European Union (NextGenerationEU).
Abstract (Originalsprache)
Background
Next-generation sequencing (NGS), particularly whole-exome sequencing (WES), has become a powerful diagnostic tool for rare genetic conditions. However, its success rate varies based on the underlying genetic etiology and the population studied.
Methods
This retrospective study evaluated the diagnostic yield of NGS in a cohort of 137 pediatric patients with suspected rare genetic disorders in Bulgaria, a setting where such testing is not reimbursed and must be self-funded. The patients underwent either WES or targeted gene panel testing based on clinical presentation, family history, and genetic evaluation.
Results
The overall diagnostic yield was 45.99%, with WES achieving 51.25% and targeted testing achieving 38.60%. The highest yield was observed in patients presenting with both dysmorphic features and neurodevelopmental delays (62.5%), while the lowest was observed among those with isolated neurodevelopmental issues (10%). A significant portion of the identified variants (35.9%) were novel. Eight patients were diagnosed with copy number variants (CNVs) detected only through WES.
Conclusions
Our findings illustrate the value of WES as a first-line test and highlight the impact of deep phenotyping on diagnostic success. This study also emphasizes the need for a population-specific reference genome and equal access to genomic diagnostics in all European countries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Genetics, Medical University Varna, Marin Drinov Str 55, 9000 Varna, Bulgaria.
- Laboratory of Medical Genetics, St. Marina Hospital, Hristo Smirnenski Blv 1, 9000 Varna, Bulgaria.
ORCID-Profile: Dinnar Yahya, Mari Hachmeriyan, Mariya Levkova
Förderung
- This study is financed by the European Union-NextGenerationEU, through the National Recov-ery and Resilience Plan of the Republic of Bulgaria, project № BG-RRP…
- European Union (NextGenerationEU)
Zitieren
APA
Stoyanova, M., Yahya, D., Hachmeriyan, M., & Levkova, M. (2025). Diagnostic Yield of Next-Generation Sequencing for Rare Pediatric Genetic Disorders: A Single-Center Experience. Medical Sciences, 13(2), 75. https://doi.org/10.3390/medsci13020075
Vancouver
Stoyanova M, Yahya D, Hachmeriyan M, Levkova M. Diagnostic Yield of Next-Generation Sequencing for Rare Pediatric Genetic Disorders: A Single-Center Experience. Medical Sciences. 2025;13(2):75. doi:10.3390/medsci13020075
BibTeX
@article{Stoyanova2025,
author = {Stoyanova, Milena and Yahya, Dinnar and Hachmeriyan, Mari and Levkova, Mariya},
title = {Diagnostic Yield of Next-Generation Sequencing for Rare Pediatric Genetic Disorders: A Single-Center Experience},
journal = {Medical Sciences},
year = {2025},
volume = {13},
number = {2},
pages = {75},
doi = {10.3390/medsci13020075}
}
EUVIMED